Research field (1)：
General surgery, pediatric surgery
Research keywords (6)：
Prevention of side effects
, Chemotherapy-Induced Peripheral Neuropathy
, Hereditary Breast Cancer
, Cancer Prevention
, Systemic Therapy
, Breast Cancer
Research theme for competitive and other funds (6)：
2022 - 2025 The development of a program to promote adherence to compression therapy in elderly patients with lower limb lymphedema.
2021 - 2024 患者テキストを臨床に活かす医療言語処理基盤の構築
2020 - 2024 乳癌臨床検体を用いたホルモン治療耐性メカニズムの解明
2018 - 2021 Multicenter randomized exploratory trial to evaluate the efficacy of compression therapy with Elastic Compression Gloves and Stockings for prevention of chemotherapy-induced neuropathy in breast cancer patients
2021 - Clinical Reaserch for CIPN prevnetion
2017 - 2020 Development of breast cancer predection model using IgGFc N-glycosylation
Tomoko Izawa, Ami Kobayashi, Masahiro Kawashima, Nobuko Kawaguchi-Sakita, Akiyoshi Nakakura, Yuki Kataoka, Kenichiro Shide, Yukiko Mori, Kazuhiro Yamazaki, Masakazu Toi, et al. Quantitative analysis of the effect of docetaxel-induced edema on quality of life in patients with breast cancer and related factors: a prospective cohort study. BMC women's health. 2024. 24. 1. 165-165
Akane Higami, Masahiro Takada, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Kosuke Kawaguchi, Ayane Yamaguchi, Yasuhide Takeuchi, Yosuke Yamada, Masakazu Kawaguchi Toi. Predicting invasive disease-free survival in ER-positive, HER2-negative early breast cancer using the PAM50 risk-of-recurrence score: a retrospective analysis using single-center long-term follow-up data of Japanese patients with breast cancer. 2024
Makoto Fujino, Masahiro Kawashima, Hajime Yoshifuji, Ran Nakashima, Yosuke Yamada, Yoshiaki Matsumoto, Nobuko Kawaguchi-Sakita, Yukiko Mori, Fengling Pu, Ayane Yamaguchi, et al. Remarkable remission of symptomatic dermatomyositis after curative breast cancer surgery. International Cancer Conference Journal. 2024
Ayane Yamaguchi, Kosuke Kawaguchi, Hiroshi Ishiguro, Tatsuki R. Kataoka, Masae Torii, Chenfeng He, Nobuko Kawaguchi-Sakita, Masahiro Kawashima, Masahiro Takada, Eiji Suzuki, et al. The long-lasting anti-tumor activity of cisplatin affecting the sustainable systemic immune alteration may improve distant-disease free survival of triple-negative breast cancer in patients with a substantial residual tumor following preoperative chemotherapy: A retrospective analysis with translational research. JOURNAL OF CLINICAL ONCOLOGY. 2020. 38. 15
